News Release

 

Back
 

AmerisourceBergen Announces Date and Time for Earnings Release, Conference Call and Webcast

01/28/03

VALLEY FORGE, Pa.--(BUSINESS WIRE)--Jan. 28, 2003-- AmerisourceBergen Corporation (NYSE:ABC) today announced that it plans to release its Second Quarter Fiscal Year 2003 results on Thursday, April 24, 2003 prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 11:00 am Eastern Daylight Time on April 24, 2003.

    Participating in the conference call will be:

        R. David Yost, Chief Executive Officer
        Kurt J. Hilzinger, President & Chief Operating Officer
        Michael D. DiCandilo, Senior Vice President & Chief Financial
         Officer

    The dial-in numbers for the live call will be as follows:

        866-269-9612 from within the United States. No access code
         required.
        612-332-0802 from outside the United States. No access code
         required.

In order to ensure the widest distribution possible, the Company will be broadcasting the conference call over the Internet. The call will be accessible through AmerisourceBergen's web site, www.amerisourcebergen.com, and also through Street Events, www.streetevents.com. Users are encouraged to log on to the webcast approximately 15 minutes in advance of the scheduled start time of the call.

Following the live call, replays will be made available on the Internet and via telephone. A replay of the webcast will be posted on www.amerisourcebergen.com approximately two hours after the completion of the call and will remain available for thirty days. To access the telephone replay from within the US, dial 800-475-6701. From outside the US, dial 320-365-3844. The access code is 673719. The telephone replay will be available from 4:00 p.m. EST on April 24, 2003 to 11:59 p.m. on May 1, 2003.

About AmerisourceBergen Corporation

AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, physician's offices, alternate care and mail order facilities, independent community pharmacies, and regional chain pharmacies. The Company is also a leader in the institutional pharmacy marketplace. With more than $40 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people. For more information, go to www.amerisourcebergen.com.

Forward-Looking Statements

This press release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements herein include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the merger between AmeriSource Health Corporation and Bergen Brunswig Corporation.

The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the risk that the businesses of AmeriSource and Bergen Brunswig will not be integrated successfully; failure to obtain and retain expected synergies; and other economic, business, competitive and/or regulatory factors affecting the business of AmerisourceBergen generally.

More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its June 30, 2002 Form 10-Q, its Annual Report on Form 10-K for fiscal 2001, and AmeriSource's and Bergen's joint proxy statement-prospectus dated August 1, 2001.

AmerisourceBergen, AmeriSource and Bergen Brunswig are under no obligation to (and expressly disclaim any such obligation to) update or alter their forward-looking statements whether as a result of new information, future events or otherwise.

CONTACT: AmerisourceBergen Corporation
Michael N. Kilpatric, 610/727-7118
mkilpatric@amerisourcebergen.com


Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More